SESSION TITLE: Tobacco Cessation and Prevention Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: October 18-21, 2020 PURPOSE: Tobacco related health conditions account for a large cohort of chronic health conditions. Tobacco/Nicotine users are currently stigmatized and hence find it difficult to seek treatment. Our institution has an electronic best practice advisory which automatically populates in all smokers identified in the electronic medical record and generates a referral to the QUIT line if patient is interested in quitting. However only 25% of these patients actually engage with the QUIT line. The Tobacco Health Assessment and Treatment (THAT) Clinic is a new initiative to integrate tobacco health into mainstream pulmonary health, 1:1 patient provider interaction, engaging patients who are interested in quitting and destigmatizing tobacco treatment. METHODS: There is 1: 1 pulmonologist, tobacco nurse and patient interaction. Patients evaluated for overall tobacco health: history and physical, the Fagerström Test for Nicotine Dependence(FTND), Framingham Risk Score, prior quit attempts, obstacles, environmental triggers and severity of tobacco dependence based on the ACCP Tobacco toolkit. PFT's ordered when appropriate.The toxic effects of tobacco, nature of the addiction, nicotine hijacking the survival instincts , countering ambivalence and helping patients bring the tobacco treatment and medication interactions with proposed tobacco treatment are discussed. Patients who are newly diagnosed with COPD , ILD, asthma, other pulmonary conditions are triaged appropriately to respective clinics. A comprehensive medication review, potential medication interactions with proposed tobacco treatment and potential side effects are discussed before offering therapy. The patients who qualify for lung cancer screening are referred to low-dose CT screening for lung cancer. RESULTS: 60 pts 70%-1 visit, 27% >2 visits. Mean age 58.5 yrs, 53% women & 82% African-American.(46%) high nicotine dependence using FTND, 80% multiple quit attempts . Common triggers :stress, depression, anxiety, proximity to smokers, boredom, staying home & coffee. Comorbidities - hypertension (63%), COPD (47%), and (18%) cancer. 20/60 patients -LDCT lung cancer screening. Median Maryland area deprivation index:9 (10- worst). 40/60 active follow up , 8 quit,12 trying to quit, 20 lost to follow up. All had follow-up outreach,-total of 640 encounters of which 81% tobacco health check-in .Common combinations-nicotine patch & lozenge/gum/inhaler; Chantix & lozenge/gum/inhaler; Chantix with nicotine patch & lozenge/gum/inhaler; or Wellbutrin with nicotine patch & lozenge/gum/inhaler.Compliance with controller& rescue medications, associated with higher quit / trying to quit rates. CONCLUSIONS: 30% patients have quit/cut down- higher success rate than many other initiatives. CLINICAL IMPLICATIONS: Integrating tobacco as mainstream pulmonary health condition & treating it as one. DISCLOSURES: No relevant relationships by Janaki Deepak, source=Web Response No relevant relationships by Julia Melamed, source=Web Response